Pexidartinib
Pexidartinib is a capsule formulation containing a small-molecule receptor tyrosine kinase (RTK) inhibitor of KIT, CSF1R and FLT3 with potential antineoplastic activity.
| Catalog Number | T2115 |
| Alternative Name(s) | PLX-3397 |
| Research Area | Angiogenesis|||Tyrosine Kinase/Adaptors|||Apoptosis |
| Molecular Formula | C20H15ClF3N5 |
| CAS# | 1029044-16-3 |
| Purity | 99.66% |
| SMILES | FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1 |
| Size | 10 mg |
| Supplier Page | https://www.targetmol.com/compound/Pexidartinib |
| Additional Information | https://www.targetmol.com/datasheet/T2115 |
